Literature DB >> 26585959

A calcified amorphous tumor that developed on both sides of the atrioventricular valve annulus.

Masaki Kinoshita1, Hideki Okayama2, Go Kawamura2, Tatsuya Shigematsu2, Tatsunori Takahashi2, Toru Miyoshi2, Akinori Higaki2, Kayo Hara2, Yoshitaka Kawata2, Go Hiasa2, Tadakatsu Yamada2, Yukio Kazatani2, Yutaka Hayashi3.   

Abstract

We report a rare case of a hemodialysis patient with a calcified amorphous tumor (CAT) on both sides of the atrioventricular valve annulus. A 70-year-old female who had received hemodialysis for 23 years because of chronic glomerulonephritis presented to our hospital with acute heart failure. Echocardiography indicated the presence of mobile cardiac masses on the mitral valve and tricuspid valve annulus. We suspected the presence of a cardiac tumor or vegetation. The patient received 3 g/day sulbactam-ampicillin and 60 mg/day gentamicin. Surgery was performed on the 14th day after hospital admission. The patient underwent mitral valve replacement, tricuspid annuloplasty, and tumor resection. Based on the pathological findings, the cardiac tumor was diagnosed as a CAT.

Entities:  

Keywords:  Calcified amorphous tumor; Heart failure; Hemodialysis; Transesophageal echocardiography; Transthoracic echocardiography

Mesh:

Year:  2015        PMID: 26585959      PMCID: PMC4669369          DOI: 10.1007/s12574-015-0267-z

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN: 1349-0222


Case

A 70-year-old female had received hemodialysis for 23 years because of chronic glomerulonephritis and had undergone implantation of a dual-chamber permanent pacemaker 2 years previously because of a complete atrioventricular block. The patient presented to our hospital with exertional dyspnea and lower limb edema and was diagnosed with acute heart failure. Her body temperature was 36.3 °C, and she had a C-reactive protein concentration of 6.45 mg/dl and brain natriuretic peptide concentration of 916 pg/ml. A repeat blood culture yielded negative results. Chest radiography showed cardiomegaly and pulmonary congestion. Transthoracic echocardiography (TTE) indicated mitral annulus calcification (MAC) and severe mitral regurgitation (MR) (Fig. 1a) due to degeneration as well as moderate tricuspid regurgitation (TR). TTE showed that the MR volume and MR regurgitant fraction were 70 ml and 60 %, respectively. The TR pressure gradient was 47 mmHg. Furthermore, the TTE showed two mobile masses attached to the mitral valve and tricuspid valve annulus (Fig. 1b, d). Transesophageal echocardiography (TEE) revealed a mobile, highly echoic mass on the A1-anterior commissure and septal annulus of the tricuspid valve (Fig. 1c, e). We suspected the presence of a cardiac tumor or vegetation. The patient received 3 g/day sulbactam-ampicillin and 60 mg/day gentamicin. Surgery was performed on the 14th day after hospital admission. She underwent MVR, TAP, tumor resection, and extraction of the permanent pacing leads because infective endocarditis could not be completely excluded. MVR was selected because the anterior leaflets were resected during the tumor resection. The tumor had been attached to the A1-anterior commissure and septal annulus of the tricuspid valve and infiltrated the right ventricular septum. The pathological findings showed calcified nodules in a region of amorphous fibrinous and focal chronic inflammation (Fig. 2). We diagnosed the tumor as a CAT. After surgery, the heart failure was controlled, and the patient’s clinical course was uneventful.
Fig. 1

Transthoracic echocardiography (TTE): color doppler image showing severe mitral regurgitation (a), parasternal long-axis (b) and apical four-chamber view (d). Transesophageal echocardiography (TEE): parasternal long-axis (c) and apical four-chamber view (e). RA right atrium; RV right ventricle; LA left atrium; LV left ventricle. White arrows indicate a mobile, highly echoic mass

Fig. 2

Pathological findings. Black arrows indicate calcified nodules (a), fibrin (b), and lymphocyte and plasma cells (c)

Transthoracic echocardiography (TTE): color doppler image showing severe mitral regurgitation (a), parasternal long-axis (b) and apical four-chamber view (d). Transesophageal echocardiography (TEE): parasternal long-axis (c) and apical four-chamber view (e). RA right atrium; RV right ventricle; LA left atrium; LV left ventricle. White arrows indicate a mobile, highly echoic mass Pathological findings. Black arrows indicate calcified nodules (a), fibrin (b), and lymphocyte and plasma cells (c)

Discussion

CAT was originally described in 1997 by Reynolds and colleagues [1] as a non-neoplastic cardiac mass. Nearly 50 cases of CAT have been reported. However, this is the first report of a CAT being found on both sides of the atrioventricular valve annulus, and the diagnosis was made by histological examination. A patient with CAT usually exhibits end-stage renal failure or has received hemodialysis. Furthermore, cases of MAC-related mobile CATs, which can mimic vegetation, have been reported [2, 3]. It is thought that abnormalities in the calcium-phosphorus metabolism due to renal dysfunction may contribute to the rapid growth of this tumor. In the preoperative differential diagnosis for the tumor, we considered CAT, vegetation, another cardiac tumor, and thrombosis. The findings were atypical for vegetation because the blood culture yielded negative results, and the Duke criteria were not satisfied. However, it was very difficult to differentiate CAT from this. Therefore, histological examination is necessary to achieve a definitive diagnosis. Although the clinical prognosis is usually good, one case of a recurrent cardiac CAT in a young patient has been reported [4]. Therefore, a patient with MAC who has received hemodialysis or experienced end-stage renal failure should be carefully monitored by echocardiography.
  4 in total

1.  Two cases of calcified amorphous tumor mimicking mitral valve vegetation.

Authors:  Mikiko Fujiwara; Hiroyuki Watanabe; Takako Iino; Yusuke Kobukai; Kazuyuki Ishibashi; Hiroshi Yamamoto; Kenji Iino; Fumio Yamamoto; Hiroshi Ito
Journal:  Circulation       Date:  2012-03-13       Impact factor: 29.690

2.  Cardiac swinging calcified amorphous tumors in end-stage renal failure patients.

Authors:  Hiroshi Kubota; Yasunori Fujioka; Hideaki Yoshino; Hitoshi Koji; Ken Yoshihara; Kunihiko Tonari; Hidehito Endo; Hiroshi Tsuchiya; Hisaaki Mera; Yukiko Soga; Seiichi Taniai; Konomi Sakata; Kenichi Sudo
Journal:  Ann Thorac Surg       Date:  2010-11       Impact factor: 4.330

3.  Calcified amorphous tumor of the heart (cardiac CAT).

Authors:  C Reynolds; H D Tazelaar; W D Edwards
Journal:  Hum Pathol       Date:  1997-05       Impact factor: 3.466

4.  Recurrent cardiac calcific amorphous tumor: the CAT had a kitten.

Authors:  Michael E Fealey; William D Edwards; Carol A Reynolds; Patricia A Pellikka; Joseph A Dearani
Journal:  Cardiovasc Pathol       Date:  2007 Mar-Apr       Impact factor: 2.185

  4 in total
  4 in total

1.  Cardiac Calcified Amorphous Tumors in a Patient with Hemodialysis for Diabetic Nephropathy.

Authors:  Satoshi Yoshimura; Hiroaki Kawano; Takako Minami; Akira Tsuneto; Tomoo Nakata; Seiji Koga; Satoshi Ikeda; Tomayoshi Hayashi; Koji Maemura
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

2.  Calcified amorphous tumor located on a severely calcified mitral annulus in a patient with normal renal function.

Authors:  Ryohei Ushioda; Tomonori Shirasaka; Shinsuke Kikuchi; Hiroyuki Kamiya; Taro Kanamori
Journal:  J Surg Case Rep       Date:  2022-01-21

3.  A Case of Cardiac Calcified Amorphous Tumor Presenting with Concomitant ST-Elevation Myocardial Infarction and Occipital Stroke and a Brief Review of the Literature.

Authors:  Kyaw Kyaw; Htun Latt; Sammy San Myint Aung; Chanwit Roongsritong
Journal:  Case Rep Cardiol       Date:  2017-12-24

Review 4.  The First Report of Calcified Amorphous Tumor Associated with Infective Endocarditis: A Case Report and Review of Literature.

Authors:  Aiko Okazaki; Yu Oyama; Naoto Hosokawa; Hirokazu Ban; Yasutomo Miyaji; Sandra Moody
Journal:  Am J Case Rep       Date:  2020-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.